[Federal Register Volume 78, Number 27 (Friday, February 8, 2013)]
[Rules and Regulations]
[Pages 9311-9315]
[FR Doc No: 2013-01416]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Occupational Safety and Health Administration

29 CFR Parts 1910, 1915, and 1926

[Docket No. OSHA-H022K-2006-0062 (formerly Docket No. H022K)]
RIN 1218-AC20

Hazard Communication; Corrections and Technical Amendment

AGENCY: Occupational Safety and Health Administration (OSHA), DOL.

ACTION: Final rule: correction and technical amendment.

-----------------------------------------------------------------------

SUMMARY: OSHA is correcting its regulations that were amended by the
Hazard Communication Standard final rule, published in the Federal
Register on March 26, 2012. The majority of the corrections are to
references inadvertently missed in the original publication of the
final rule. Other corrections include correcting values or notations in
tables, and updating references to terms.

DATES: Effective: February 8, 2013.

FOR FURTHER INFORMATION CONTACT:
    Press inquiries: Frank Meilinger, Director, Office of
Communications, OSHA, Room N-3647, U.S. Department of Labor, 200
Constitution Avenue NW., Washington, DC 20210; telephone (202) 693-
1999.
    General and technical information: Dorothy Dougherty, Director,
Directorate of Standards and Guidance, OSHA, Room N-3718, U.S.
Department of Labor, 200 Constitution Avenue NW., Washington, DC 20210;
telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    This notice corrects certain minor errors in the revisions to
OSHA's Hazard Communication Standard, published at 77 FR 17574. The
majority of these corrections change references in other OSHA standards
made to ``material safety data sheet'' or ``MSDS'' to ``safety data
sheet'' or ``SDS,'' which OSHA inadvertently missed in its original
publication of the final rule. Other corrections include correcting
values or notations in tables, and updating references to terms defined
in the Hazard Communication Standard Final Rule, published on March 26,
2012.

Correction of Publication

    The following corrections are made to the preamble to the final
rule for the Hazard Communication Standard, published in the Federal
Register on March 26, 2012 (77 FR 17574).
    1. In the Preamble, on p. 17686, in the third column, the seventh
paragraph Estimated Total Burden Hours: 11.3 million hours is revised
to read Estimated Total Burden Hours: 10,689,248 hours.
    2. In the Preamble, on p. 17755, in the third column, in the first
paragraph the name ``David Levine'' is corrected to read ``Daniel
Levine''.
    3. In the Preamble, on p. 17712, Table XIII-1, the ``>20%'' value
for Specific target organ toxicity Category 3 is corrected to read
``>=20%'' (both columns).
    4. In the Preamble, on p. 17751, Table XIII-5, Health Effects
Column for Standard No. 1910.1051. ``Cancer; eye and respiratory tract
irritation; center nervous system effects; and flammability'' is
corrected to read

``Cancer; eye and respiratory tract irritation; central nervous system
effects; and flammability.''
    The following table contains a summary of the codified changes made
to the Hazard Communication final rule as it appeared at 77 FR 17574
and is provided for the regulated community. The changes are listed by
the Federal Register page number on which they can be found, the
standard being corrected, and a summary of the correction being made.

----------------------------------------------------------------------------------------------------------------
                Page No.                            Standard                           Correction
----------------------------------------------------------------------------------------------------------------
Page 17776, third column................  Sec.   1910.119, paragraph   ``material safety data sheet'' and the
                                           (d)(1) and Appendix C.       acronym ``MSDS'' are corrected to
                                                                        ``safety data sheet'' and ``SDS'',
                                                                        respectively.
On p. 17776, third column...............  Sec.   1910.120, paragraph   ``material safety data sheet'' and the
                                           (g), Appendices A and E.     acronym ``MSDS'' are corrected to
                                                                        ``safety data sheet'' and ``SDS'',
                                                                        respectively.
On p. 17778, first column...............  Sec.   1910.1001, Appendix   ``material safety data sheet'' and the
                                           J.                           acronym ``MSDS'' are corrected to
                                                                        ``safety data sheet'' and ``SDS'',
                                                                        respectively.
On p. 17782, third column...............  Sec.   1910.1044, Appendix   Reference to ``Class IIIA combustible
                                           B.                           liquid'' is corrected to ``Category 4
                                                                        flammable liquid''.
On p. 17784, first column...............  Sec.   1910.1048, Appendix   The flammability class reference in
                                           A.                           Appendix A is updated to align with the
                                                                        Sec.   1910.1200.
On p. 17785, second column, second        Sec.   1910.1051 (l)(1)(ii)  ``center nervous system effects'' is
 paragraph.                                                             corrected to ``central nervous system
                                                                        effects''.
On p. 17785, second column..............  Sec.   1910.1052, Appendix   The example label language in Appendix A
                                           A.                           is removed and the Appendix is corrected
                                                                        to reference classification and label
                                                                        requirements provided in Sec.
                                                                        1910.1200. ``material safety data
                                                                        sheet'' and the acronym ``MSDS'' are
                                                                        corrected to ``safety data sheet'' and
                                                                        ``SDS''.
On p. 17786.............................  Sec.   1910.1200, Appendix   Remove the entire Appendix E entitled,
                                           E.                           ``Appendix E to Sec.   1910.1200--
                                                                        (Advisory)--Guidelines for Employer
                                                                        Compliance''.
On p. 17787.............................  Sec.   1910.1200,            Remove paragraphs (d)(4), (d)(5), and
                                           paragraphs (d)(4), (d)(5),   (d)(6).
                                           and (d)(6).
On p. 17791.............................  Sec.   1910.1200, Appendix   Remove the word ``Steward''.
                                           A, Table A.1.1 Note (a).
On p. 17791.............................  Sec.   1910.1200, Appendix   Dermal Category 1 value of ``<=5'' is
                                           A, Paragraph A.1.2, Table    corrected to read ``<=50''.
                                           A.1.1.
On p. 17797.............................  Sec.   1910.1200, Appendix   The concentration of ``relevant
                                           A, Paragraph A.<IP_ADDRESS>.      ingredients'' of a mixture is corrected
                                                                        from ``>1%'' to ``>=1%''.
On p. 17801.............................  Sec.   1910.1200, Appendix   The concentration of ``relevant
                                           A, Paragraph A.<IP_ADDRESS>.      ingredients'' of a mixture is corrected
                                                                        from ``>1%'' to ``>=1%''.
On p. 17818.............................  Sec.   1910.1200, Appendix   Reformat table to clarify application of
                                           B, Paragraph B.3.2, Table    hazard categories.
                                           B.3.1.
On p. 17886.............................  Sec.   1910.1200, Appendix   Correct the paragraph numbering in the
                                           F, Part A.                   first column. The second subsection
                                                                        under the heading Carcinogenicity in
                                                                        experimental animals is corrected to
                                                                        read ``(b)''.
On p. 17887.............................  Sec.   1910.1200, Appendix   The NTP RoC column of the Table is
                                           F, Part D.                   corrected to indicate that the text
                                                                        ``Reasonably Anticipated (See Note 1)''
                                                                        is intended to refer to both lines (IARC
                                                                        Group 2A and 2B, and GHS Category 1B and
                                                                        2), and the subparagraphs in paragraph 3
                                                                        of Note 1 are corrected to ``a'' and
                                                                        ``b'' rather than ``c'' and ``d''.
On p. 17888.............................  Sec.   1915.1001, Appendix   ``material safety data sheet'' and the
                                           K.                           acronym ``MSDS'' are corrected to
                                                                        ``safety data sheet'' and ``SDS'',
                                                                        respectively.
On p. 17890.............................  Sec.   1926.64, Appendix C.  ``material safety data sheet'' and the
                                                                        acronym ``MSDS'' are corrected to
                                                                        ``safety data sheet'' and ``SDS'',
                                                                        respectively.
On p. 17890.............................  Sec.   1926.65, Appendix E.  ``material safety data sheet'' is
                                                                        corrected to ``safety data sheet''.
On p. 17895.............................  Sec.   1926.1101, paragraph  Paragraphs (k)(8)(iv)(B) and (k)(8)(v)
                                           (k)(8)(v).                   are repetitive; paragraph (k)(8)(v) is
                                                                        designated as ``Reserved.''
----------------------------------------------------------------------------------------------------------------

II. Exemption From Notice-and-Comment Procedures

    Section 4 of the Administrative Procedure Act, 5 U.S.C.
553(b)(3)(B), provides that, when an Agency for good cause finds that
notice and public procedure are impracticable, unnecessary or contrary
to the public interest, the Agency may issue a final rule without
providing notice and an opportunity for public comment. This rulemaking
only corrects errors of a minor, mainly typographical nature and
therefore does not affect or change any existing rights or obligations.
OSHA has determined that there is good cause, pursuant to 5 U.S.C.
553(b)(3)(B), Section 6(b) of the Occupational Safety and Health Act of
1970 (29 U.S.C. 655(b)), and 29 CFR 1911.5, for making this
correctional amendment final without prior proposal and opportunity for
comment because the rulemaking does not affect or change any existing
rights or obligations, and no stakeholder is likely to object to them.
For the same reasons, the Agency finds good cause under 5 U.S.C.
553(d)(3) to make the amendment effective upon publication.

III. Authority and Signature

    David Michaels, Ph.D., MPH, Assistant Secretary for Occupational
Safety and Health, U.S. Department of Labor, 200 Constitution Avenue
NW., Washington, DC 20210, authorized the preparation of this document.
It is issued under the authority of sections 4, 6, and 8 of the
Occupational Safety and Health Act of 1970 (29 U.S.C. 653, 655, 657); 5
U.S.C. 553; Section 304, Clean Air Act Amendments of 1990 (Pub. L. 101-
549, reprinted at 29 U.S.C.A. 655 Note); Section 41, Longshore and
Harbor Workers' Compensation Act (33 U.S.C. 941); Section 107, Contract
Work Hours and Safety Standards Act (40 U.S.C. 3704); Section 1031,
Housing and Community Development Act of 1992 (42 U.S.C. 4853); Section
126, Superfund Amendments and Reauthorization Act of 1986, as

amended (reprinted at 29 U.S.C.A. 655 Note); Secretary of Labor's Order
No. 1-2012 (77 FR 3912); and 29 CFR Part 1911.

David Michaels,
Assistant Secretary of Labor for Occupational Safety and Health.

List of Subjects

29 CFR Part 1910

    Asbestos, Chemicals, Fire prevention, Hazard communication,
Hazardous substances, Occupational safety and health.

29 CFR Part 1915

    Asbestos, Longshore and harbor workers, Occupational safety and
health.

29 CFR Part 1926

    Asbestos, Construction industry, Fire prevention, Hazardous
substances, Occupational safety and health.

    Accordingly, OSHA is amending 29 CFR parts 1910, 1915, and 1926 by
making the following corrections and technical amendments:

PART 1910--OCCUPATIONAL SAFETY AND HEALTH STANDARDS

Subpart H--[Amended]

0
1. The authority citation for Part 1910 Subpart H continues to read as
follows:

    Authority:  Sections 4, 6, and 8 of the Occupational Safety and
Health Act of 1970 (29 U.S.C. 653, 655, 657); Secretary of Labor's
Order No. 12-71 (36 FR 8754), 8-76 (41 FR 25059), 9-83 (48 FR
35736), 1-90 (55 FR 9033), 6-96 (62 FR 111), 3-2000 (65 FR 50017),
or 5-2007 (72 FR 31159), 4-2010 (75 FR 55355) or 1-2012 (77 FR
3912), as applicable; and 29 CFR part 1911.
    Sections 1910.103, 1910.106 through 1910.111, and 1910.119,
1910.120, and 1910.122 through 1910.126 also issued under 29 CFR
part 1911.
    Section 1910.119 also issued under Section 304, Clean Air Act
Amendments of 1990 (Pub. L. 101-549), reprinted at 29 U.S.C.A. 655
Note.
    Section 1910.120 also issued under Section 126, Superfund
Amendments and Reauthorization Act of 1986 as amended (29 U.S.C.A.
655 Note), and 5 U.S.C. 553.

Sec.  1910.119  [Amended]

0
2. Amend Sec.  1910.119 as follows:
0
a. Remove the words ``Material Safety Data Sheets'' and add in their
place ``safety data sheets'' in the note following paragraph (d)(1).
0
b. In Appendix C to Sec.  1910.119, remove ``material safety data sheet
(MSDS)'' in the second paragraph in section 3 and add in its place
``safety data sheet (SDS)'' and remove ``MSDS'' in the first paragraph
in section 6 and add in its place ``SDSs''.
0
c. In Appendix C to Sec.  1910.119, remove the words ``material safety
data sheets'' and add in their place ``safety data sheets'' in the
seventh paragraph in section 13.

Sec.  1910.120  [Amended]

0
3. Amend Sec.  1910.120:
0
a. By removing the acronym ``MSDS'' and adding in its place ``SDS''
wherever it appears; and
0
b. In Appendix E to Sec.  1910.120, by removing the words ``material
safety data sheets'' and adding in their place ``safety data sheets''
wherever they appear.

Subpart Z--[Amended]

0
4. The authority citation for Part 1910 Subpart Z continues to read as
follows:

    Authority: Sections 4, 6, 8 of the Occupational Safety and
Health Act of 1970 (29 U.S.C. 653, 655, 657); Secretary of Labor's
Order No. 12-71 (36 FR 8754), 8-76 (41 FR 25059), 9-83 (48 FR
35736), 1-90 (55 FR 9033), 6-96 (62 FR 111), 3-2000 (65 FR 50017),
5-2002 (67 FR 65008), 5-2007 (72 FR 31159), 4-2010 (75 FR 55355), or
1-2012 (77 FR 3912), as applicable; and 29 CFR part 1911.
    All of subpart Z issued under section 6(b) of the Occupational
Safety and Health Act of 1970, except those substances that have
exposure limits listed in Tables Z-1, Z-2, and Z-3 of 29 CFR
1910.1000. The latter were issued under section 6(a) (29 U.S.C.
655(a)).
    Section 1910.1000, Tables Z-1, Z-2 and Z-3 also issued under 5
U.S.C. 553, but not under 29 CFR part 1911 except for the arsenic
(organic compounds), benzene, cotton dust, and chromium (VI)
listings.
    Section 1910.1001 also issued under section 107 of the Contract
Work Hours and Safety Standards Act (40 U.S.C. 3704) and 5 U.S.C.
553.
    Section 1910.1002 also issued under 5 U.S.C. 553, but not under
29 U.S.C. 655 or 29 CFR part 1911.
    Sections 1910.1018, 1910.1029, and 1910.1200 also issued under
29 U.S.C. 653.
    Section 1910.1030 also issued under Pub. L. 106-430, 114 Stat.
1901.
    Section 1910.1201 also issued under 49 U.S.C. 1801-1819 and 5
U.S.C. 533.

Sec.  1910.1001  [Amended]

0
5. Amend Sec.  1910.1001 as follows:
0
a. Remove the words ``material safety data sheet'' and add in their
place ``safety data sheet'' wherever they appear in Appendix J;
0
b. Remove the acronym ``MSDS'' and add in its place ``SDS'' wherever it
appears in Appendix J.

Sec.  1910.1044  [Amended]

0
6. Amend Sec.  1910.1044 as follows:
0
a. Remove the phrase ``Class IIIA combustible liquid'' and add in its
place ``Category 4 flammable liquid'' wherever it appears in Appendix
B.

Sec.  1910.1048  [Amended]

0
7. Amend Sec.  1910.1048 by removing the phrase ``Flammability Class
(OSHA): III A'' and adding in its place ``Flammability (OSHA): Category
4 flammable liquid'' wherever it appears in Appendix A.

0
8. Amend Sec.  1910.1051 by revising paragraph (l)(1)(ii) to read as
follows:

Sec.  1910.1051  1,3-Butadiene.

* * * * *
    (l) * * *
    (1) * * *
    (ii) In classifying the hazards of BD at least the following
hazards are to be addressed: Cancer; eye and respiratory tract
irritation; central nervous system effects; and flammability.
* * * * *

0
9. Amend Sec.  1910.1052, in Appendix A, by revising paragraph E in
section X to read as follows:

Sec.  1910.1052  Methylene Chloride.

* * * * *

Appendix A to Sec.  1910.1052--Substance Safety Data Sheet and
Technical Guidelines for Methylene Chloride

* * * * *

X. Access to Information

* * * * *
    E. Your employer is required to provide labels and safety data
sheets (SDSs) for all materials, mixtures or solutions composed of
greater than 0.1 percent MC. These materials, mixtures or solutions
would be classified and labeled in accordance with Sec.  1910.1200.
* * * * *

0
10. Amend Sec.  1910.1200 as follows:
0
a. Remove paragraphs (d)(4) through (6).
0
b. Remove the word ``Steward'' in Appendix A, Table A.1.1 Note (a).
0
c. Remove the value of ``<=5'' and add in its place ``<=50'' for Dermal
Category 1 in Appendix A, paragraph A.1.2, Table A.1.1.
0
d. In Appendix A, revise paragraphs A.<IP_ADDRESS> and A.<IP_ADDRESS>.
0
e. In Appendix B, in paragraph B.3.2, revise Table B.3.1.
0
f. Remove the second occurrence of Appendix E (entitled ``(Advisory)--
Guidelines for Employer Compliance'').
0
g. In Appendix F, in Part A, redesignate the second paragraph (a) under
``carcinogenicity in experimental animals'' as paragraph (b) and revise
Part D.
    The revisions read as follows:

Sec.  1910.1200  Hazard Communication.

* * * * *

Appendix A to Sec.  1910.1200--Health Hazard Criteria (Mandatory)

* * * * *

A.1 ACUTE TOXICITY

* * * * *

                Table A.1.1--Acute Toxicity Hazard Categories and Acute Toxicity Estimate (ATE) Values Defining the Respective Categories
--------------------------------------------------------------------------------------------------------------------------------------------------------
           Exposure route             Category 1              Category 2                         Category 3                        Category 4
--------------------------------------------------------------------------------------------------------------------------------------------------------
Oral (mg/kg bodyweight)
    see: Note (a)..................         <= 5  >5 and <= 50.....................  >50 and <= 300...................  >300 and <= 2000.
    Note (b)
Dermal (mg/kg bodyweight)
    see: Note (a)..................        <= 50  >50 and <= 200...................  >200 and <= 1000.................  >1000 and <= 2000.
    Note (b)
Inhalation--Gases (ppmV)
    see: Note (a)..................       <= 100  >100 and <= 500..................  >500 and <= 2500.................  >2500 and <= 20000.
    Note (b)
    Note (c)
Inhalation--Vapors (mg/l)
    see: Note (a)..................       <= 0.5  >0.5 and <= 2.0..................  >2.0 and <= 10.0.................  >10.0 and <= 20.0.
    Note (b)
    Note (c)
    Note (d)
Inhalation--Dusts and Mists (mg/l)
    see: Note (a)..................      <= 0.05  >0.05 and <= 0.5.................  >0.5 and <= 1.0..................  >1.0 and <= 5.0.
    Note (b)
    Note (c)
--------------------------------------------------------------------------------------------------------------------------------------------------------

* * * * *

A.2 SKIN CORROSION/IRRITATION

* * * * *
    A.2.4
    * * *
    A.2.4.3
    * * *
    A.<IP_ADDRESS>. For purposes of classifying the skin corrosion/
irritation hazards of mixtures in the tiered approach:
    The ``relevant ingredients'' of a mixture are those which are
present in concentrations >=1% (weight/weight for solids, liquids,
dusts, mists and vapors and volume/volume for gases.) If the
classifier has reason to suspect that an ingredient present at a
concentration <1% will affect classification of the mixture for skin
corrosion/irritation, that ingredient shall also be considered
relevant.
* * * * *

A.3 SERIOUS EYE DAMAGE/EYE IRRITATION

* * * * *
    A.3.4 * * *
    A.3.4.3 * * *
    A.<IP_ADDRESS> For purposes of classifying the eye corrosion/
irritation hazards of mixtures in the tiered approach:
    The ``relevant ingredients'' of a mixture are those which are
present in concentrations >=1% (weight/weight for solids, liquids,
dusts, mists and vapors and volume/volume for gases.) If the
classifier has reason to suspect that an ingredient present at a
concentration <1% will affect classification of the mixture for eye
corrosion/irritation, that ingredient shall also be considered
relevant.
* * * * *

Appendix B to Sec.  1910.1200--Physical Hazard Criteria (Mandatory)

* * * * *

B.3 FLAMMABLE AEROSOLS

* * * * *

B.3.2 Classification Criteria

* * * * *

              Table B.3.1--Criteria for Flammable Aerosols
------------------------------------------------------------------------
           Category                             Criteria
------------------------------------------------------------------------
1............................  Contains >= 85% flammable components and
                                the chemical heat of combustion is >= 30
                                kJ/g; or
                               (a) For spray aerosols, in the ignition
                                distance test, ignition occurs at a
                                distance >= 75 cm (29.5 in), or
                               (b) For foam aerosols, in the aerosol
                                foam flammability test
                               (i) The flame height is >= 20 cm (7.87
                                in) and the flame duration >= 2 s; or
                               (ii) The flame height is >= 4 cm (1.57
                                in) and the flame duration >= 7 s
2............................  Contains > 1% flammable components, or
                                the heat of combustion is >= 20 kJ/g;
                                and
                               (a) for spray aerosols, in the ignition
                                distance test, ignition occurs at a
                                distance >= 15 cm (5.9 in), or
                               in the enclosed space ignition test, the
                               (i) Time equivalent is <= 300 s/m\3\; or
                               (ii) Deflagration density is <= 300 g/
                                m\3\
                               (b) For foam aerosols, in the aerosol
                                foam flammability test, the flame height
                                is >= 4 cm and the flame duration is >=
                                2 s
                               and it does not meet the criteria for
                                Category 1
------------------------------------------------------------------------

* * * * *

Appendix F to Sec.  1910.1200--Guidance for Hazard Classifications Re:
Carcinogenicity (Non-Mandatory)

* * * * *

Part D: Table Relating Approximate Equivalences Among IARC, NTP RoC,
and GHS Carcinogenicity Classifications

    The following table may be used to perform hazard
classifications for carcinogenicity under the HCS (Sec.  1910.1200).
It relates the approximated GHS hazard categories for
carcinogenicity to the classifications provided by IARC and NTP, as
described in Parts B and C of this Appendix.

    Approximate Equivalences Among Carcinogen Classification Schemes
------------------------------------------------------------------------
             IARC                      GHS                NTP RoC
------------------------------------------------------------------------
Group 1.......................  Category 1A......  Known.
Group 2A......................  Category 1B......  Reasonably
                                                    Anticipated (See
                                                    Note 1).
Group 2B......................  Category 2.......  Reasonably
                                                    Anticipated (See
                                                    Note 1).
------------------------------------------------------------------------

    Note 1:
    1. Limited evidence of carcinogenicity from studies in humans
(corresponding to IARC 2A/GHS 1B);
    2. Sufficient evidence of carcinogenicity from studies in
experimental animals (again, essentially corresponding to IARC 2A/
GHS 1B);
    3. Less than sufficient evidence of carcinogenicity in humans or
laboratory animals; however:
    a. The agent, substance, or mixture belongs to a well-defined,
structurally-related class of substances whose members are listed in
a previous RoC as either ``Known'' or ``Reasonably Anticipated'' to
be a human carcinogen, or
    b. There is convincing relevant information that the agent acts
through mechanisms indicating it would likely cause cancer in
humans.
* * * * *

PART 1915--OCCUPATIONAL SAFETY AND HEALTH STANDARDS FOR SHIPYARD
EMPLOYMENT

Subpart Z--[Amended]

0
11. The authority citation for Part 1915 continues to read as follows:

    Authority: Section 41, Longshore and Harbor Workers'
Compensation Act (33 U.S.C. 941); Sections. 4, 6, and 8 of the
Occupational Safety and Health Act of 1970 (29 U.S.C. 653, 655,
657); Secretary of Labor's Order No. 12-71 (36 FR 8754), 8-76 (41 FR
25059), 9-83 (48 FR 35736), 1-90 (55 FR 9033), 6-96 (62 FR 111), 3-
2000 (65 FR 50017), 5-2002 (67 FR 65008), 5-2007 (72 FR 31160), 4-
2010 (75 FR 55355), or 1-2012 (77 FR 3912), as applicable; and 29
CFR Part 1911.
    Section 1915.100 also issued under 49 U.S.C. 1801-1819 and 5
U.S.C. 553.
    Sections 1915.120 and 1915.152 of 29 CFR also issued under 29
CFR part 1911.

Sec.  1915.1001  [Amended]

0
12. Amend Sec.  1915.1001 by removing the words ``Material Safety Data
Sheet'' and adding in their place ``safety data sheet'' and removing
the acronym ``MSDS'' and adding in its place ``SDS'' in Appendix K,
section 3.1.(e).

PART 1926--OCCUPATIONAL SAFETY AND HEALTH STANDARDS FOR
CONSTRUCTION

Subpart D--[Amended]

0
13. The authority citation for Part 1926 Subpart D continues to read as
follows:

    Authority: Section 107 of the Contract Work Hours and Safety
Standards Act (40 U.S.C. 3704); Sections 4, 6, and 8 of the
Occupational Safety and Health Act of 1970 (29 U.S.C. 653, 655, and
657); and Secretary of Labor's Order No. 12-71 (36 FR 8754), 8-76
(41 FR 25059), 9-83 (48 FR 35736), 1-90 (55 FR 9033), 6-96 (62 FR
111), 3-2000 (65 FR 50017), 5-2002 (67 FR 65008), 5-2007 (72 FR
31159), 4-2010 (75 FR 55355), or 1-2012 (77 FR 3912) as applicable;
and 29 CFR part 1911.
    Sections 1926.58, 1926.59, 1926.60, and 1926.65 also issued
under 5 U.S.C. 553 and 29 CFR part 1911.
    Section 1926.61 also issued under 49 U.S.C. 1801-1819 and 6
U.S.C. 553.
    Section 1926.62 also issued under section 1031 of the Housing
and Community Development Act of 1992 (42 U.S.C. 4853).
    Section 1926.65 also issued under section 126 of the Superfund
Amendments and Reauthorization Act of 1986, as amended (reprinted at
29 U.S.C.A. 655 Note), and 5 U.S.C. 553.

Sec.  1926.64  [Amended]

0
14. Amend Sec.  1926.64 as follows:
0
a. Remove the words ``material safety data sheet'' and add in their
place ``safety data sheet'' wherever they appear in Appendix C;
0
b. Remove the words ``material safety data sheets'' and add in their
place ``safety data sheets'' wherever they appear in Appendix C;
0
c. Remove the acronym ``MSDS'' and add in its place ``SDS'' wherever it
appears in Appendix C.

Sec.  1926.65  [Amended]

0
15. Amend Sec.  1926.65 by removing the words ``material safety data
sheets'' and adding in their place ``safety data sheets'' wherever they
appear in Appendix E.

Subpart Z--[Amended]

0
16. The authority citation for Part 1926 Subpart Z continues to read as
follows:

    Authority: Section 107 of the Contract Work Hours and Safety
Standards Act (40 U.S.C. 3704); Sections 4, 6, and 8 of the
Occupational Safety and Health Act of 1970 (29 U.S.C. 653, 655,
657); and Secretary of Labor's Order No. 12-71 (36 FR 8754), 8-76
(41 FR 25059), 9-83 (48 FR 35736), 1-90 (55 FR 9033), 6-96 (62 FR
111), 3-2000 (65 FR 50017), 5-2002 (67 FR 65008), 5-2007 (72 FR
31159), 4-2010 (75 FR 55355), or 1-2012 (77 FR 3912) as applicable;
and 29 CFR part 1911.
    Section 1926.1102 not issued under 29 U.S.C. 655 or 29 CFR part
1911; also issued under 5 U.S.C. 553.

Sec.  1926.1101  [Amended]

0
17. Amend Sec.  1926.1101 remove and reserve paragraph (k)(8)(v).

[FR Doc. 2013-01416 Filed 2-7-13; 8:45 am]
BILLING CODE 4510-26-P


[Federal Register: July 12, 2006 (Volume 71, Number 133)]
[Notices]
[Page 39316-39318]
[DOCID:fr12jy06-66]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2006-0523; FRL-8074-3]

Notice of Filing of Pesticide Petitions for Establishment and
Amendment to Regulations for Residues of Thiamethoxam in or on Various
Commodities

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the initial filing of pesticide
petitions proposing the establishment or amendment of regulations for
residues of pesticide chemicals in or on various commodities.

DATES: Comments must be received on or before August 11, 2006.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2006-0523 and pesticide petition number (PP)
6E7060, 0F6142, and 9F5051, by one of the following methods:-
    - Federal eRulemaking Portal: http://www.regulations.gov.

Follow the on-line instructions for submitting comments.
    - Mail: Office of Pesticide Programs (OPP) Regulatory
Public Docket (7502P), Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington, DC 20460-0001.
    - Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Building), 2777 S. Crystal Drive, Arlington, VA. Deliveries are only
accepted during the Docket's normal hours of operation (8:30 a.m. to 4
p.m., Monday through Friday, excluding legal holidays). Special
arrangements should be made for deliveries of boxed information. The
Docket Facility telephone number is<PHONE_NUMBER>.
    -Instructions: Direct your comments to docket ID number EPA-HQ-OPP-
2006-0523. EPA's policy is that all comments received will be included
in the docket

without change and may be made available on-line at http://www.regulations.gov
, including any personal information provided,

unless the comment includes information claimed to be Confidential
Business Information (CBI) or other information whose disclosure is
restricted by statute. Do not submit information that you consider to
be CBI or otherwise protected through regulations.gov or e-mail. The
Federal regulations.gov website is an ``anonymous access'' system,
which means EPA will not know your identity or contact information
unless you provide it in the body of your comment. If you send an e-
mail comment directly to EPA without going through regulations.gov,
your e-mail address will be automatically captured and included as part
of the comment that is placed in the docket and made available on the
Internet. If you submit an electronic comment, EPA recommends that you
include your name and other contact information in the body of your
comment and with any disk or CD-ROM you submit. If EPA cannot read your
comment due to technical difficulties and cannot contact you for
clarification, EPA may not be able to consider your comment. Electronic
files should avoid the use of special characters, any form of
encryption, and be free of any defects or viruses.
    -Docket: All documents in the docket are listed in the docket
index. Although listed in the index, some information is not publicly
available, e.g., CBI or other information whose disclosure is
restricted by statute. Certain other material, such as copyrighted
material, is not placed on the Internet and will be publicly available
only in hard copy form. Publicly available docket materials are
available either in the electronic docket at http://www.regulations.gov
, or, if only available in hard copy, at the OPP

Regulatory Public Docket in Rm. S-4400, One Potomac Yard (South
Building), 2777 S. Crystal Drive, Arlington, VA. The hours of operation
of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday through
Friday, excluding legal holidays. The Docket Facility telephone number
is<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: For Pesticide Petition Information:
Registration Division (7505 P), Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington, DC 20460-0001.
    For PP 6E7060: Barbara Madden; telephone number:<PHONE_NUMBER>; e-
mail address<EMAIL_ADDRESS>    For PP 0F6142 and 9F5051: Dani Daniel; telephone number: (703) 305-
5409; e-mail address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    -You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to:
    - Crop production (NAICS code 111).
    - Animal production (NAICS code 112).
    - Food manufacturing (NAICS code 311).
    - Pesticide manufacturing (NAICS code 32532).
    -This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the person listed under FOR FURTHER INFORMATION
CONTACT.

B. What Should I Consider as I Prepare My Comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or e-mail. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD ROM that you mail to EPA, mark the outside of the disk or CD ROM as
CBI and then identify electronically within the disk or CD ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.-
    2. Tips for preparing your comments. When submitting comments,
remember to:
    -i. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
    -ii. Follow directions. The Agency may ask you to respond to
specific questions or organize comments by referencing a Code of
Federal Regulations (CFR) part or section number.
    -iii. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
    -iv. Describe any assumptions and provide any technical information
and/or data that you used.
    -v. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
    -vi. Provide specific examples to illustrate your concerns and
suggest alternatives.
    -vii. Explain your views as clearly as possible, avoiding the use
of profanity or personal threats.
    -viii. Make sure to submit your comments by the comment period
deadline identified.

II. What Action is the Agency Taking?

    -EPA is printing a summary of each pesticide petition received
under section 408 of the Federal Food, Drug, and Cosmetic Act (FFDCA),
21 U.S.C. 346a, proposing the establishment or amendment of regulations
in 40 CFR part 180 for residues of pesticide chemicals in or on various
food commodities. EPA has determined that this pesticide petition
contains data or information regarding the elements set forth in FFDCA
section 408(d)(2); however, EPA has not fully evaluated the sufficiency
of the submitted data at this time or whether the data support granting
of the pesticide petition. Additional data may be needed before EPA
rules on this pesticide petition.
    -Pursuant to 40 CFR 180.7(f), a summary of the petition included in
this notice, prepared by the petitioner along with a description of the
analytical method available for the detection and measurement of the
pesticide chemical residues is available on EPA's Electronic Docket at
http://www.regulations.gov. To locate this information on the home page

of EPA's Electronic Docket, select ``Quick Search'' and type the OPP
docket ID number. Once the search has located the docket, clicking on
the ``Docket ID'' will bring up a list of all documents in the docket
for the pesticide including the petition summary.

New Tolerance

    1. PP 6E7060. Interregional Research Project Number 4 (IR-4), 681
U.S. Highway 1 South, North Brunswick, NJ 08902-3390, proposes
to establish a tolerance for residues of the insecticide, thiamethoxam
[3-[(2-chloro-5-thiazolyl)methyl]tetrahydro-5-methyl-N-nitro-4H-1,3,5-
oxadiazin-4-imine] (CAS

Reg. No. 153719-23-4) and its metabolite [N-(2-chloro-thiazol-5-
ylmethyl)-N'-methyl -N'-nitro-guanidine] in or on food commodities
caneberry subgroup 13A at 0.30 parts per million (ppm); hops at 0.1
ppm; Globe artichoke at 0.4 ppm and increase tolerance levels for
exisiting tolerances for barley, grain at 0.3 ppm; barley, hay at 0.4
ppm; and barley, straw at 0.4.
    2. PP 0F6142. Syngenta Crop Protection Inc., P.O. Box 18300,
Greensboro, NC 27419-8300, to establish a tolerance for residues of the
insecticide, thiamethoxam [3-[(2-chloro-5-thiazolyl)methyl]tetrahydro-
5-methyl-N-nitro-4H-1,3,5-oxadiazin-4-imine] (CAS Reg. No. 153719-23-4)
and its metabolite [N-(2-chloro-thiazol-5-ylmethyl)-N'-methyl -N'-
nitro-guanidine] in or on food commodities grapes at 0.15 ppm; grape,
juice at 0.20 ppm; and raisins at 0.30 ppm.
    3. PP 9F5051. Syngenta Crop Protection Inc., P.O. Box 18300,
Greensboro, NC 27419-8300, proposes to establish a tolerance for
residues of the insecticide, thiamethoxam [3-[(2-chloro-5-
thiazolyl)methyl]tetrahydro-5-methyl-N-nitro-4H-1,3,5-oxadiazin-4-
imine] (CAS Reg. No. 153719-23-4) and its metabolite [N-(2-chloro-
thiazol-5-ylmethyl)-N'-methyl -N'-nitro-guanidine] in or on food
commodities vegetable, leafy, except brassica, group 4 at 2.0 ppm;
brassica, leafy greens, subgroup 5B at 2.0 ppm ; brassica, head and
stem, subgroup 5A at 1.0 ppm.
    For all three petitions (PP 6E7060, 0F6142 and 9F5051) the
analytical method used to measure and evaluate the chemical residue is
based on crop specific cleanup procedures and determination by liquid
chromatography with either ultraviolet (UV) or mass spectrometry (MS)
detection. The limit of detection (LOD) for each analyte of this method
is 1.25 ng injected for samples analyzed by UV and 0.25 ng injected for
samples analyzed by MS, and the limit of quantitation (LOQ) is 0.005
ppm for milk and juices and 0.01 ppm for all other substrates.

List of Subjects

    -Environmental protection, Agricultural commodities, Feed
additives, Food additives, Pesticides and pests, Reporting and
recordkeeping requirements.

    Dated: June 28, 2006.
Donald R. Stubbs,
Acting Director, Registration Division, Office of Pesticide Programs.

[FR Doc. E6-10859 Filed 7-11-06; 8:45 am]

BILLING CODE 6560-50-S


[Federal Register: November 25, 2009 (Volume 74, Number 226)]
[Rules and Regulations]
[Page 61516-61517]
[DOCID:fr25no09-8]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 510, 520, 522, and 558

[Docket No. FDA-2009-N-0665]

New Animal Drugs; Change of Sponsor

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor for 29 new animal drug
applications (NADAs) and 2 abbreviated new animal drug applications
(ANADAs) from Intervet, Inc., to Schering-Plough Animal Health Corp.

DATES:  This rule is effective November 25, 2009.

FOR FURTHER INFORMATION CONTACT: David R. Newkirk, Center for
Veterinary Medicine (HFV-100), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855,<PHONE_NUMBER>, e-mail:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Intervet, Inc., P.O. Box 318, 29160 Intervet
Lane, Millsboro, DE 19966, has informed FDA that it has transferred
ownership of, and all rights and interest in, the following 29 approved
NADAs and 2 approved ANADAs to Schering-Plough Animal Health Corp., 556
Morris Ave., Summit, NJ 07901: NADA 034-478, 034-621, 045-188, 102-380,
104-494, 111-278, 120-648, 121-473, 128-620, 131-310, 131-675, 132-872,
137-600, 138-612, 139-189, 140-856, 140-897, 140-927, 140-954, 140-992,
141-222, 141-236, 141-258, 141-269, 141-276, 141-278, 141-280, 141-282,
141-286; ANADA 200-134 and 200-239. Accordingly, the agency is amending
the regulations in 21 CFR parts 520, 522 (21 CFR part 522), and 558 to
reflect the transfer of ownership. In addition, Sec.  522.1081 is being
revised to reflect a current format.
    Following these changes of sponsorship, Intervet, Inc., is no
longer the sponsor of an approved application. Accordingly, 21 CFR
510.600(c) is being amended to remove the entries for Intervet, Inc.
    This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.

List of Subjects

21 CFR Part 510

    Administrative practice and procedure, Animal drugs, Labeling,
Reporting and recordkeeping requirements.

21 CFR Parts 520 and 522

    Animal drugs.

21 CFR Part 558

    Animal drugs, Animal feeds.

0
Therefore, under the Federal Food, Drug and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR parts 510,
520, 522, and 558 are amended as follows:

PART 510--NEW ANIMAL DRUGS

0
1. The authority citation for 21 CFR part 510 continues to read as
follows:

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

Sec.  510.600  [Amended]

0
2. In Sec.  510.600, in the table in paragraph (c)(1), remove the entry
for ``Intervet, Inc.''; and in the table in paragraph (c)(2), remove
the entry for ``057926''.

PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS

0
3. The authority citation for 21 CFR part 520 continues to read as
follows:

    Authority: 21 U.S.C. 360b.

Sec.  520.48  [Amended]

0
4. In paragraph (b) of Sec.  520.48, remove ``057926'' and in its place
add ``000061''.

Sec.  520.905a  [Amended]

0
5. In paragraph (b) of Sec.  520.905a, remove ``057926'' and in its
place add ``000061''.

Sec.  520.905b  [Amended]

0
6. In paragraph (b) of Sec.  520.905b, remove ``057926'' and in its
place add ``000061''.

Sec.  520.905c  [Amended]

0
7. In paragraph (b) of Sec.  520.905c, remove ``057926'' and in its
place add ``000061''.

Sec.  520.905d  [Amended]

0
8. In paragraph (b)(1) of Sec.  520.905d, remove ``057926'' and in its
place add ``000061''.

Sec.  520.905e  [Amended]

0
9. In paragraph (b) of Sec.  520.905e, remove ``057926'' and in its
place add ``No. 000061''.

Sec.  520.1010  [Amended]

0
10. In paragraph (b)(2) of Sec.  520.1010, remove ``057926'' and in its
place add ``000061''.

Sec.  520.1200  [Amended]

0
11. In paragraph (b) of Sec.  520.1200, remove ``057926'' and in its
place add ``000061''.

PART 522--IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

0
12. The authority citation for 21 CFR part 522 continues to read as
follows:

    Authority: 21 U.S.C. 360b.

Sec.  522.246  [Amended]

0
13. In paragraph (b)(3) of Sec.  522.246, remove ``057926'' and in its
place add ``000061''.

Sec.  522.1010  [Amended]

0
14. In paragraph (b)(4) of Sec.  522.1010, remove ``057926'' and in its
place add ``000061''.

Sec.  522.1078  [Amended]

0
15. In paragraph (b) of Sec.  522.1078, remove ``Nos. 050604, 057926,
and 059130'' and in its place add ``Nos. 000061, 050604, and 059130''.

Sec.  522.1079  [Amended]

0
16. In paragraph (b) of Sec.  522.1079, remove ``057926'' and in its
place add ``000061''.

0
17. Revise Sec.  522.1081 to read as follows:

Sec.  522.1081  Chorionic gonadotropin.

    (a) Specifications. Each vial contains 5,000, 10,000 or 20,000 USP
units of lyophilized powder for constitution with accompanying diluent
to a 10-milliliter solution.

    (b) Sponsors. See sponsors in Sec.  510.600(c) of this chapter for
use as in paragraph (d) of this section.
    (1) Nos. 000402 and 053501 for use as in paragraphs (d)(1)(i)(A),
(d)(1)(i)(B) and (d)(1)(i)(C) of this section.
    (2) Nos. 058639 and 063323 for use as in paragraphs (d)(1)(i)(A)
and (d)(1)(i)(B) of this section.
    (3) No. 000061 for use as in paragraphs (d)(1)(i)(A) and (d)(2) of
this section.
    (c) Related tolerances. See Sec.  556.304 of this chapter.
    (d) Conditions of use--(1) Cattle--(i) Amount. As a single dose.
Dosage may be repeated in 14 days if the animal's behavior or
examination of the ovaries per rectum indicates retreatment.
    (A) 10,000 USP units by intramuscular injection.
    (B) 500 to 2,500 USP units by intrafollicular injection.
    (C) 2,500 to 5,000 USP units by intravenous injection.
    (ii) Indications for use. For parenteral use in cows for treatment
of nymphomania (frequent or constant heat) due to cystic ovaries.
    (iii) Limitations. Federal law restricts this drug to use by or on
the order of a licensed veterinarian.
    (2) Finfish--(i) Amount. 50 to 510 IU per pound of body weight for
males, 67 to 1,816 IU per pound of body weight for females, by
intramuscular injection. Up to three doses may be administered.
    (ii) Indications for use. An aid in improving spawning function in
male and female brood finfish.
    (iii) Limitations. In fish intended for human consumption, the
total dose administered per fish (all injections combined) should not
exceed 25,000 IU chorionic gonadotropin. Federal law restricts this
drug to use by or on the order of a licensed veterinarian.

Sec.  522.1160  [Amended]

0
18. In paragraph (b) of Sec.  522.1160, remove ``057926'' and in its
place add ``000061''.

Sec.  522.2476  [Amended]

0
19. In paragraph (a)(2) of Sec.  522.2476, remove ``057926'' and in its
place add ``000061''.

Sec.  522.2477  [Amended]

0
20. In paragraph (b)(2) of Sec.  522.2477, remove ``057926'' and in its
place add ``000061''.

PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

0
21. The authority citation for 21 CFR part 558 continues to read as
follows:

    Authority: 21 U.S.C. 360b, 371.

Sec.  558.258  [Amended]

0
22. In paragraph (b) of Sec.  558.258, remove ``057926'' and in its
place add ``000061''; and in the tables in paragraphs (e)(1) through
(e)(5), in the ``Sponsor'' column, remove ``057926'' where it occurs
and in its place add ``000061''.

Sec.  558.665  [Amended]

0
23. In paragraph (b) of Sec.  558.665, remove ``057926'' and in its
place add ``000061''; and in the table in paragraph (e), in the
``Sponsor'' column, remove ``057926'' where it occurs and in its place
add ``000061''.

    Dated: November 19, 2009.
Steven D. Vaughn,
Director, Office of New Animal Drug Evaluation, Center for Veterinary
Medicine.
[FR Doc. E9-28217 Filed 11-24-09; 8:45 am]

BILLING CODE 4160-01-S


[Federal Register Volume 86, Number 16 (Wednesday, January 27, 2021)]
[Notices]
[Pages 7287-7288]
[FR Doc No: 2021-01757]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER15-1471-011; ER10-1874-012; ER10-2721-010; ER10-
2861-009; ER12-1308-012; ER13-1504-010; ER15-1672-010; ER16-2010-005;
ER16-2561-005; ER16-711-008; ER16-915-004; ER19-2287-002; ER19-2289-
002; ER19-2294-002; ER19-2305-002; ER19-9-006.
    Applicants: Blue Sky West, LLC, Comanche Solar PV, LLC, El Paso
Electric Company, Evergreen Wind Power II, LLC, Fountain Valley Power,
L.L.C., Goal Line L.P., Hancock Wind, LLC, KES Kingsburg, L.P., Mankato
Energy Center, LLC, Mankato Energy Center II, LLC, Mesquite Power, LLC,
Palouse Wind, LLC, Pio Pico Energy Center, LLC, Sunflower Wind Project,
LLC, SWG Arapahoe, LLC, Valencia Power, LLC.
    Description: Notice of Non-Material Change in Status of Blue Sky
West, LLC, et al.
    Filed Date: 1/19/21.
    Accession Number: 20210119-5245.
    Comments Due: 5 p.m. ET 2/9/21.

    Docket Numbers: ER15-632-011; ER14-2140-011; ER14-2141-011; ER14-
2465-012; ER14-2466-012; ER14-2939-009; ER15-1952-009; ER15-2728-011;
ER15-634-011.
    Applicants: CID Solar, LLC, Cottonwood Solar, LLC, RE Columbia Two,
LLC, RE Camelot, LLC, Pavant Solar, LLC, Imperial Valley Solar Company
(IVSC) 2, LLC, Maricopa West Solar PV, LLC, Mulberry Farm, LLC, Selmer
Farm, LLC.
    Description: Notice of Non-Material Change in Status of Dominion
Companies.
    Filed Date: 1/19/21.
    Accession Number: 20210119-5250.
    Comments Due: 5 p.m. ET 2/9/21.

    Docket Numbers: ER16-505-006.
    Applicants: GridLiance High Plains LLC.
    Description: Compliance filing: Gridliance HP Supplemental
Compliance Filing ER15-2594 to be effective N/A.
    Filed Date: 1/19/21.
    Accession Number: 20210119-5163.
    Comments Due: 5 p.m. ET 2/9/21.

    Docket Numbers: ER20-1505-003.
    Applicants: Basin Electric Power Cooperative, Inc.
    Description: Notice of Change in Status of Basin Electric Power
Cooperative.
    Filed Date: 1/19/21.
    Accession Number: 20210119-5244.
    Comments Due: 5 p.m. ET 2/9/21.

    Docket Numbers: ER21-786-001.
    Applicants: Trans Bay Cable LLC.
    Description: Tariff Amendment: Revisions to the Annual TRBAA Filing
2020 to be effective 1/1/2021.
    Filed Date: 1/21/21.
    Accession Number: 20210121-5239.
    Comments Due: 5 p.m. ET 2/11/21.

    Docket Numbers: ER21-916-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Amendment to ISA/ICSA; Queue
No. AC1-068 to be effective 1/28/2019.
    Filed Date: 1/21/21.
    Accession Number: 20210121-5004.
    Comments Due: 5 p.m. ET 2/11/21.

    Docket Numbers: ER21-917-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Amendment to ISA/CSA, SA
Nos. 5920 and 5308; Queue No. AC1-069 to be effective 1/28/2019.

    Filed Date: 1/21/21.
    Accession Number: 20210121-5005.
    Comments Due: 5 p.m. ET 2/11/21.

    Docket Numbers: ER21-918-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Amendment to ISA/CSA, SA
Nos. 5291 and 5312 ; Queue No. AC1-165 to be effective 1/28/2019.
    Filed Date: 1/21/21.
    Accession Number: 20210121-5006.
    Comments Due: 5 p.m. ET 2/11/21.

    Docket Numbers: ER21-919-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Amendment to ISA/CSA, SA
Nos. 5409 and 5410 ; Queue No. AC1-166 to be effective 5/15/2019.
    Filed Date: 1/21/21.
    Accession Number: 20210121-5007.
    Comments Due: 5 p.m. ET 2/11/21.

    Docket Numbers: ER21-920-000.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: Sec.  205(d) Rate Filing: 2021-01-21_Demand Response
Testing Deferral and Collateral Handling to be effective 3/23/2021.
    Filed Date: 1/21/21.
    Accession Number: 20210121-5090.
    Comments Due: 5 p.m. ET 2/11/21.

    Docket Numbers: ER21-921-000.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: Sec.  205(d) Rate Filing: 2021-01-21_SA 3634
Certificate of Concurrence LGE-KU-BREC 1st Rev IA to be effective 12/
31/2020.
    Filed Date: 1/21/21.
    Accession Number: 20210121-5096.
    Comments Due: 5 p.m. ET 2/11/21.

    Docket Numbers: ER21-922-000.
    Applicants: Entergy Mississippi, LLC.
    Description: Tariff Cancellation: EML-TVA WDS Agreement
Cancellation to be effective 11/1/2020.
    Filed Date: 1/21/21.
    Accession Number: 20210121-5116.
    Comments Due: 5 p.m. ET 2/11/21.

    Docket Numbers: ER21-923-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Tariff Cancellation: Notice of Cancellation of Tariff
ID 3292-Western Energy Imbalance Service Tariff to be effective 2/1/
2021.
    Filed Date: 1/21/21.
    Accession Number: 20210121-5117.
    Comments Due: 5 p.m. ET 2/11/21.

    Docket Numbers: ER21-924-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Tariff Cancellation: Notice of Cancellation of Tariff
ID 3310-WEIS Rate Schedule Tariff to be effective 2/1/2021.
    Filed Date: 1/21/21.
    Accession Number: 20210121-5122.
    Comments Due: 5 p.m. ET 2/11/21.

    Docket Numbers: ER21-925-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Sec.  205(d) Rate Filing: Corrections to Schedule 1 to
be effective 4/1/2021.
    Filed Date: 1/21/21.
    Accession Number: 20210121-5189.
    Comments Due: 5 p.m. ET 2/11/21.

    Take notice that the Commission received the following electric
securities filings:

    Docket Numbers: ES21-27-000.
    Applicants: The Empire District Electric Company.
    Description: Application Under Section 204 of the Federal Power Act
for Authorization to Issue Securities of The Empire District Electric
Company.
    Filed Date: 1/19/21.
    Accession Number: 20210119-5237.
    Comments Due: 5 p.m. ET 2/9/21.

    Take notice that the Commission received the following public
utility holding company filings:

    Docket Numbers: PH21-6-000.
    Applicants: IIF US Holding 2 GP, LLC.
    Description: IIF US Holding 2 GP, LLC submits FERC-65-A Notice of
Non-Material Change in Fact to Waiver Notification.
    Filed Date: 1/19/21.
    Accession Number: 20210119-5243.
    Comments Due: 5 p.m. ET 2/9/21.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: January 21, 2021.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2021-01757 Filed 1-26-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 81, Number 35 (Tuesday, February 23, 2016)]
[Notices]
[Page 9067]
[FR Doc No: 2016-03846]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Sunshine Act Meeting

    Notice is hereby given, pursuant to the provisions of the
Government in the Sunshine Act, Public Law 94-409, that the Securities
and Exchange Commission Advisory Committee on Small and Emerging
Companies will hold a public meeting on Thursday, February 25, in
Multi-Purpose Room LL-006 at the Commission's headquarters, 100 F
Street NE., Washington, DC.
    The meeting will begin at 9:30 a.m. (EST) and will be open to the
public. Seating will be on a first-come, first-served basis. Doors will
open at 9:00 a.m. Visitors will be subject to security checks. The
meeting will be webcast on the Commission's Web site at www.sec.gov.
    On February 5, 2016, the Commission published notice of the
Committee meeting (Release No. 33-10034), indicating that the meeting
is open to the public and inviting the public to submit written
comments to the Committee. This Sunshine Act notice is being issued
because a majority of the Commission may attend the meeting.
    The agenda for the meeting includes matters relating to rules and
regulations affecting small and emerging companies under the federal
securities laws.
    For further information, please contact the Office of the Secretary
at<PHONE_NUMBER>.

     Dated: February 18, 2016.
Brent J. Fields,
Secretary.
[FR Doc. 2016-03846 Filed 2-19-16; 4:15 pm]
 BILLING CODE 8011-01-P


[Federal Register Volume 85, Number 17 (Monday, January 27, 2020)]
[Notices]
[Pages 4768-4769]
[FR Doc No: 2020-01278]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[FMCSA Docket No. FMCSA-2019-0036]

Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of final disposition.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces its decision to exempt seven individuals from
the requirement in the Federal Motor Carrier Safety Regulations
(FMCSRs) that interstate commercial motor vehicle (CMV) drivers have
``no established medical history or clinical diagnosis of epilepsy or
any other condition which is likely to cause loss of consciousness or
any loss of ability to control a CMV.'' The exemptions enable these
individuals who have had one or more seizures and are taking anti-
seizure medication to operate CMVs in interstate commerce.

DATES: The exemptions were applicable on January 10, 2020. The
exemptions expire on January 10, 2022.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
ET, Monday through Friday, except Federal holidays. If you have
questions regarding viewing or submitting material to the docket,
contact Docket Operations,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Public Participation

A. Viewing Documents and Comments

    To view comments, as well as any documents mentioned in this notice
as being available in the docket, go to http://www.regulations.gov/docket?D=FMCSA-2019-0036 and choose the document to review. If you do
not have access to the internet, you may view the docket online by
visiting the Docket Operations in Room W12-140 on the ground floor of
the DOT West Building, 1200 New Jersey Avenue SE, Washington, DC 20590,
between 9 a.m. and 5 p.m., ET, Monday through Friday, except Federal
holidays.

B. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the
public to better inform its rulemaking process. DOT posts these
comments, without edit, including any personal information the
commenter provides, to www.regulations.gov, as described in the system
of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.transportation.gov/privacy.

II. Background

    On December 4, 2019, FMCSA published a notice announcing receipt of
applications from seven individuals requesting an exemption from the
epilepsy and seizure disorders prohibition in 49 CFR 391.41(b)(8) and
requested comments from the public (84 FR 66446). The public comment
period ended on January 3, 2020, and one comment was received.
    FMCSA has evaluated the eligibility of these applicants and
determined that granting exemptions to these individuals would achieve
a level of safety equivalent to, or greater than, the level that would
be achieved by complying with Sec.  391.41(b)(8).
    The physical qualification standard for drivers regarding epilepsy
found in Sec.  391.41(b)(8) states that a person is physically
qualified to drive a CMV if that person has no established medical
history or clinical diagnosis of epilepsy or any other condition which
is likely to cause the loss of consciousness or any loss of ability to
control a CMV.
    In addition to the regulations, FMCSA has published advisory
criteria \1\ to assist medical examiners (MEs) in determining whether
drivers with certain medical conditions are qualified to operate a CMV
in interstate commerce.
---------------------------------------------------------------------------

    \1\ These criteria may be found in APPENDIX A TO PART 391--
MEDICAL ADVISORY CRITERIA, section H. Epilepsy: Sec.  391.41(b)(8),
paragraphs 3, 4, and 5, which is available on the internet at
https://www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/CFR-2015-title49-vol5-part391-appA.pdf.
---------------------------------------------------------------------------

III. Discussion of Comments

    FMCSA received one comment in this proceeding that supported
granting these exemptions.

IV. Basis for Exemption Determination

    Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption
from the FMCSRs for no longer than a 5-year period if it finds such
exemption would likely achieve a level of safety that is equivalent to,
or greater than, the level that would be

achieved absent such exemption. The statute also allows the Agency to
renew exemptions at the end of the 5-year period. FMCSA grants medical
exemptions from the FMCSRs for a 2-year period to align with the
maximum duration of a driver's medical certification.
    The Agency's decision regarding these exemption applications is
based on the 2007 recommendations of the Agency's Medical Expert Panel
(MEP). The Agency conducted an individualized assessment of each
applicant's medical information, including the root cause of the
respective seizure(s) and medical information about the applicant's
seizure history, the length of time that has elapsed since the
individual's last seizure, the stability of each individual's treatment
regimen and the duration of time on or off of anti-seizure medication.
In addition, the Agency reviewed the treating clinician's medical
opinion related to the ability of the driver to safely operate a CMV
with a history of seizure and each applicant's driving record found in
the Commercial Driver's License Information System for commercial
driver's license (CDL) holders, and interstate and intrastate
inspections recorded in the Motor Carrier Management Information
System. For non-CDL holders, the Agency reviewed the driving records
from the State Driver's Licensing Agency (SDLA). A summary of each
applicant's seizure history was discussed in the December 4, 2019,
Federal Register notice (84 FR 66446) and will not be repeated in this
notice.
    These seven applicants have been seizure-free over a range of 18
years while taking anti-seizure medication and maintained a stable
medication treatment regimen for the last 2 years. In each case, the
applicant's treating physician verified his or her seizure history and
supports the ability to drive commercially.
    The Agency acknowledges the potential consequences of a driver
experiencing a seizure while operating a CMV. However, the Agency
believes the drivers granted this exemption have demonstrated that they
are unlikely to have a seizure and their medical condition does not
pose a risk to public safety.
    Consequently, FMCSA finds that in each case exempting these
applicants from the epilepsy and seizure disorder prohibition in Sec.
391.41(b)(8) is likely to achieve a level of safety equal to that
existing without the exemption.

V. Conditions and Requirements

    The terms and conditions of the exemption are provided to the
applicants in the exemption document and includes the following: (1)
Each driver must remain seizure-free and maintain a stable treatment
during the 2-year exemption period; (2) each driver must submit annual
reports from their treating physicians attesting to the stability of
treatment and that the driver has remained seizure-free; (3) each
driver must undergo an annual medical examination by a certified ME, as
defined by Sec.  390.5; and (4) each driver must provide a copy of the
annual medical certification to the employer for retention in the
driver's qualification file, or keep a copy of his/her driver's
qualification file if he/she is self-employed. The driver must also
have a copy of the exemption when driving, for presentation to a duly
authorized Federal, State, or local enforcement official.

VI. Preemption

    During the period the exemption is in effect, no State shall
enforce any law or regulation that conflicts with this exemption with
respect to a person operating under the exemption.

VII. Conclusion

    Based upon its evaluation of the seven exemption applications,
FMCSA exempts the following drivers from the epilepsy and seizure
disorder prohibition, Sec.  391.41(b)(8), subject to the requirements
cited above:

David Crouch (KY)
Demetrius Furman (SD)
Christopher Gilbert (VA)
Jeffrey Koesterer (MO)
Kevin Market (OH)
Randy Wentz (PA)
Robert Williams (IL)

    In accordance with 49 U.S.C. 31315(b), each exemption will be valid
for 2 years from the effective date unless revoked earlier by FMCSA.
The exemption will be revoked if the following occurs: (1) The person
fails to comply with the terms and conditions of the exemption; (2) the
exemption has resulted in a lower level of safety than was maintained
prior to being granted; or (3) continuation of the exemption would not
be consistent with the goals and objectives of 49 U.S.C. 31136(e) and
31315(b).

    Issued on: January 17, 2020.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2020-01278 Filed 1-24-20; 8:45 am]
 BILLING CODE 4910-EX-P


################################################################################
################################################################################
#
# MRM2 model including Canadian studies, but not Rudd et al.
# Prep script for Chib method
################################################################################
################################################################################

# Note: to run the entire script, select everything, then click on "Run"
# otherwise "Run" will execute only the selected line

# Preliminary housekeeping
################################################################################
# set working directory to keep file paths short
setwd('C:/Users/55338/ICF/WOTUS Reconsideration (ICF Internal Site) - General/Wetland Meta-Analysis/Wetland MRM - R Code/')

rm(list = ls(all = TRUE)) #first, clear R's workspace
options(prompt = "R> ", digits = 4) # show 4 digits by default
options(continue=" ") #remove continuation prompt
#
set.seed(37)  #sets the random number generator so we can reproduce results
#
tic<-proc.time() #start stop watch
#
# load packages we'll need
############################
library("xtable")
library("MASS")   #for draws from the multivariate normal
library("stats")  #for draws from the gamma
library("mvtnorm")#for draws from the multivariate t
library("MCMCpack") #for draws from the inverse gamma
library("openxlsx") #to copy output to excel

################################################################################
#Load and Prepare Data
################################################################################
#
# read tab-delimited text data (easiest way to load)
# header=TRUE also loads variable names
#data<- read.table('./data/wetlanddataFeb2022.txt', sep="\t", header=TRUE)
data<- read.table('./data/wetlanddataJune2022_corrected.txt', sep="\t", header=TRUE)
#
# save in R-format, for future loading
#save(data, file = "./data/wetlanddataFeb2022.rda")
save(data, file = "./data/wetlanddataJune2022.rda")

# % contents of data
# %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
# % 1   studyid         original unique study id
# % 2   obsid           original unique observation id
# % 3   lnwtp           log of wtp2021
# % 4   wlfresh         1=freshwater wetland, 0 = salt/coastal
# % 5   lnyear          log of yr of data collection - 1988
# % 6   lninc           log of inc2021
# % 7   sagulf          1 = S-Atlantic/Gulf, study involves AL,GA,SC,LA
# % 8   nema            1 = ME/mid-Atlantic, study involves DE,MD,NJ,PA,RI
# % 9   nmw             N/Mid-West, study involves KY,MI,NE,OH,WI
# % 10  CAN             1 = Canadian study
# % 11  local           f1= local scale (target pop at sub-state level)
# % 12  prov            1=provisioning function affected
# % 13  reg             1=regulating function affected
# % 14  cult            1=cultural function affected
# % 15  forest          1=forested wetland
# % 16  q0              baseline acreage
# % 17  q1              policy acreage
# % 18  volunt          1= pay mech = voluntary contribution
# % 19  lumpsum         1=single payment
# % 20  ce              choice experiment
# % 21  nrev            1=not peer-reviewed
# % 22  median          1=orig. wtp based on econometric medians
# % 23  q0alt           alternative definition of baseline acres - see notes
# % 24  q1alt           alternative definition of policy acres - see notes
# % 25  wetdens         affected waterbody area divided by area of geographic scope
# % 26  distdec         population-weighted age distance of all CBGs (or counties) in samples area to affected water body

# note: missing values for wetdens and distdec coded as "-999"

# Drop Rudd et al observations
################################
#data<-subset(data,data[,1]!=128)

# Drop Hindsley and Yoskowitz observations (remove comment to drop)
################################
#data<-subset(data,data[,1]!=130)

# Drop Nijhum thesis observations (remove comment to drop)
################################
#data<-subset(data,data[,1]!=132)

# keep freshwater only
###############################
data<-subset(data,data[,4]==1)

# define y and X
###############################
q0<-data[,16]/1000
q1<-data[,17]/1000

y<-as.matrix(data[,3]-log(q1-q0))
n<-length(y)

X<-as.matrix(cbind(rep(1,n),data[,5:15],(q0+q1)/2, data[18:19]))
k<-ncol(X)

# % contents of X
# %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
# % 1   const           constant
# % 2   lnyear          log of yr of data collection - 1988
# % 3   lninc           log of inc2021
# % 4   sagulf          1 = S-Atlantic/Gulf, study involves AL,GA,SC,LA
# % 5   nema            1 = ME/mid-Atlantic, study involves DE,MD,NJ,PA,RI
# % 6   nmw             N/Mid-West, study involves KY,MI,NE,OH,WI
# % 7   CAN             1 = Canadian study
# % 8   local           f1= local scale (target pop at sub-state level)
# % 9   prov            1=provisioning function affected
# % 10  reg             1=regulating function affected
# % 11  cult            1=cultural function affected
# % 12  forest          1=forested wetland
# % 13  (q0+q1)/2
# % 14  volunt          1= pay mech = voluntary contribution
# % 15  lumpsum         1=single payment

################################################################################
# Starting values, priors, and tuners
################################################################################

r1<-0  #burn-ins - don't need any for Chib
r2<-100000  #keepers
R<-r1+r2

# generic OLS to get starting values
####################################
bols<-solve((t(X)) %*% X) %*% (t(X) %*% y)
e<-y-X%*%bols
SSR<-(t(e)%*%e)
s2<-(t(e)%*%e)/(n-k)

#PRIORS:
###################
#for beta:
mu0<-rep(0,k)
V0<-10*diag(k)

#for sig2:
v0<-1/2
tau0<-1/2

# Load GS results
######################
#load("./output using Feb22 data/MRM2_CAN_32obs.rda")
load("./output using June22 data/MRM2_CAN_32obs.rda")

################################################################################
# call Chib function
################################################################################
#I generally adopt the name of the original GS and add "_chib"
source("./functions/gs_normal_independent_chib.R")  #call the function

int<-gs_normal_independent_chib(X,y,n,k,r1,r2,mu0,V0,betadraw,v0,tau0,sig2draw,betamat,sig2mat)

# contents of int:
# logpmarg
# lp
# llf
# lpost

################################################################################
# output table
################################################################################
# coefficients, followed by sig2
chibout<-as.data.frame(as.matrix(int)) #4 by 1
colnames(chibout)<-c("chib output")
rownames(chibout)<- c("log-marg-lh","log prior", "log-lh", "log-posterior")

# you can now open the table in the "Global Environment" window and copy/paste it
# to Excel etc.

################################################################################
# save your output for further processing
################################################################################
#save(chibout,file = "./output using Feb22 data/MRM2_CAN_32obs_chib.rda")
save(chibout,file = "./output using June22 data/MRM2_CAN_32obs_chib.rda")

################################################################################
# OR send directly to excel
################################################################################
#write.xlsx(chibout,"./output using Feb22 data/MRM2_CAN_32obs_chib.xlsx",row.names=TRUE)
write.xlsx(chibout,"./output using June22 data/MRM2_CAN_32obs_chib.xlsx",row.names=TRUE)

proc.time()-tic #capture run time


[Federal Register Volume 78, Number 206 (Thursday, October 24, 2013)]
[Notices]
[Page 63528]
[FR Doc No: 2013-25121]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Sunshine Act Meeting

    Notice is hereby given, pursuant to the provisions of the
Government in the Sunshine Act, Public Law 94-409, that the Securities
and Exchange Commission will hold an Open Meeting on Wednesday, October
23, 2013 at 10:00 a.m., in the Auditorium, Room L-002.
    The subject matter of the Open Meeting will be:
     The Commission will consider whether to propose rules and
forms related to the offer and sale of securities through crowdfunding
pursuant to Section 4(a)(6) of the Securities Act of 1933, as mandated
by Title III of the Jumpstart Our Business Startups Act.
    The duty officer has determined that no earlier notice was
possible.
    At times, changes in Commission priorities require alterations in
the scheduling of meeting items.
    For further information and to ascertain what, if any, matters have
been added, deleted or postponed, please contact: The Office of the
Secretary at<PHONE_NUMBER>.

     Dated: October 21, 2013.
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2013-25121 Filed 10-22-13; 11:15 am]
BILLING CODE 8011-01-P